Kneat.com Partners with Global Pharma to Digitize Validation
Company Announcements

Kneat.com Partners with Global Pharma to Digitize Validation

Story Highlights

kneat.com (TSE:KSI) has released an update.

Kneat.com, a leader in digitizing validation and quality processes, has signed a three-year Master Services Agreement with a major global pharmaceutical company to digitize its validation processes, starting with Computer System Validation. The partnership aims to boost efficiency, accuracy, and compliance across the company’s international operations.

For further insights into TSE:KSI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskKneat.com Completes $35.6 Million Financing Round
TipRanks Canadian Auto-Generated NewsdeskKneat.com Announces Equity Financing Prospectus
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App